Bcl-B inhibitor 1

CAS No. 79220-88-5

Bcl-B inhibitor 1( —— )

Catalog No. M36960 CAS No. 79220-88-5

Bcl-B inhibitor 1 is an antitumor compound that binds to and inactivates pro-apoptotic proteins in the BH3 structural domain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 38 Get Quote
10MG 61 Get Quote
25MG 98 Get Quote
50MG 143 Get Quote
100MG 205 Get Quote
500MG 511 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Bcl-B inhibitor 1
  • Note
    Research use only, not for human use.
  • Brief Description
    Bcl-B inhibitor 1 is an antitumor compound that binds to and inactivates pro-apoptotic proteins in the BH3 structural domain.
  • Description
    Bcl-B inhibitor 1 is a Bcl-B inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis | BCL
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    79220-88-5
  • Formula Weight
    309.39
  • Molecular Formula
    C17H15N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S=C1N(C=C(N1)C2=CC=CC=C2)C3=CC=C(NC(C)=O)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Siva Rajesh, et al. Computational designing of novel inhibitors to Bcl-B, an anti-apoptotic protein, using fragment-based drug designing approach. Romanian Biotechnological Letters 18(5):8613-8621.
molnova catalog
related products
  • FC-116

    FC-116 is a potent Tubulin inhibitor with antitumour activity and inhibits tumour growth in mice.

  • Stearoylethanolamide

    Stearoylethanolamide(N-(2-Hydroxyethyl)octadecanamide) is a cannabinoid compound present in the brains of humans, rats, and mice with pro-apoptotic activity.

  • CMLD-2

    CMLD-2 is an inhibitor of HuR-ARE interaction (Ki: 350 nM) that competitively binds HuR protein and disrupts its interaction with adenine element-rich (ARE) mRNA targets.